Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is resveratrol the magic bullet for pulmonary hypertension?

× No keyword cloud information.

11 in total

1. Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis.

Authors: Bertrand Poussier; Alfredo C Cordova; Jean-Pierre Becquemin; Bauer E Sumpio
Journal: J Vasc Surg Date: 2005-12 Impact factor: 4.268

2. Upregulated TRP and enhanced capacitative Ca(2+) entry in human pulmonary artery myocytes during proliferation.

Authors: V A Golovina; O Platoshyn; C L Bailey; J Wang; A Limsuwan; M Sweeney; L J Rubin; J X Yuan
Journal: Am J Physiol Heart Circ Physiol Date: 2001-02 Impact factor: 4.733

Review 3. Role of ion channels in acute and chronic responses of the pulmonary vasculature to hypoxia.

Authors: E Kenneth Weir; Andrea Olschewski
Journal: Cardiovasc Res Date: 2006-04-27 Impact factor: 10.787

4. Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism.

Authors: M A Birrell; K McCluskie; S Wong; L E Donnelly; P J Barnes; M G Belvisi
Journal: FASEB J Date: 2005-02-25 Impact factor: 5.191

Review 5. Cardiovascular protective effects of resveratrol.

Authors: Silvia Bradamante; Livia Barenghi; Alessandro Villa
Journal: Cardiovasc Drug Rev Date: 2004

6. Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats.

Authors: Anna Csiszar; Nazar Labinskyy; Susan Olson; John T Pinto; Sachin Gupte; Joseph M Wu; Furong Hu; Praveen Ballabh; Andrej Podlutsky; Gyorgy Losonczy; Rafael de Cabo; Rajamma Mathew; Michael S Wolin; Zoltan Ungvari
Journal: Hypertension Date: 2009-07-13 Impact factor: 10.190

7. Roles of MAPK and NF-kappaB in interleukin-6 induction by lipopolysaccharide in vascular smooth muscle cells.

Authors: Yong-Hae Son; Yeon-Tae Jeong; Kyeong-Ah Lee; Kyung-Ha Choi; Sun-Mi Kim; Byung-Yong Rhim; Koanhoi Kim
Journal: J Cardiovasc Pharmacol Date: 2008-01 Impact factor: 3.105

8. Resveratrol inhibits rat aortic vascular smooth muscle cell proliferation via estrogen receptor dependent nitric oxide production.

Authors: Viktoriya P Ekshyyan; Valeria Y Hebert; Alok Khandelwal; Tammy R Dugas
Journal: J Cardiovasc Pharmacol Date: 2007-07 Impact factor: 3.105

9. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms.

Authors: Louise E Donnelly; Robert Newton; Gina E Kennedy; Peter S Fenwick; Rachel H F Leung; Kazuhiro Ito; Richard E K Russell; Peter J Barnes
Journal: Am J Physiol Lung Cell Mol Physiol Date: 2004-06-04 Impact factor: 5.464

Review 10. Evidence-based pharmacologic management of pulmonary arterial hypertension.

Authors: Neal Benedict; Amy Seybert; Michael A Mathier
Journal: Clin Ther Date: 2007-10 Impact factor: 3.393

7 in total

1. Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.

Authors: Michael L Paffett; Selita N Lucas; Matthew J Campen
Journal: Vascul Pharmacol Date: 2011-11-25 Impact factor: 5.773

Review 2. NADPH oxidase: its potential role in promotion of pulmonary arterial hypertension.

Authors: Jing-Jie Peng; Bin Liu; Jin-Yun Xu; Jun Peng; Xiu-Ju Luo
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2017-02-11 Impact factor: 3.000

3. Resveratrol inhibits hypoxia-induced proliferation and migration of pulmonary artery vascular smooth muscle cells by inhibiting the phosphoinositide 3-kinase/protein kinase B signaling pathway.

Authors: Zhanjiang Guan; Li Shen; Huan Liang; Haitao Yu; Bingchang Hei; Xianguo Meng; Lei Yang
Journal: Mol Med Rep Date: 2017-06-20 Impact factor: 2.952

Is resveratrol the magic bullet for pulmonary hypertension?